:be Aktie 113268981 / AT0000A2SGH0
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
19.11.2025 15:53:00
|
Stock Split Watch: Could This Unstoppable Growth Stock Be Next?
Eli Lilly (NYSE: LLY) has had a tumultuous year. The pharmaceutical giant lagged the market for much of it, due to worse-than-expected financial results and a clinical setback.However, the Eli Lilly has roared back and is up 32% year to date. The stock price now exceeds $1,000, which could potentially make the drugmaker a candidate for a stock split, a move that would attract even more attention to the company. Should investors expect it to announce a stock split anytime soon?While stock splits don't strengthen a company's underlying business, corporations do them for several reasons. One is to keep the price of their shares within a "reasonable" window that makes it attractive to most investors. A stock priced at, say, $100,000 per share is likely to discourage many buyers from even considering it.Continue readingWeiter zum vollständigen Artikel bei MotleyFool